Organ Transplantation Research Today is a free monthly online journal that collates and summarizes the latest research about Organ Transplantation, including details on risks, prognosis, procedure, surgery.

Volume 2 (2005), Issue 6 (June)

1. Cystatin-C and creatinine as indices of glomerular filtration rate in the immediate follow-up of renal transplant patients.
   Clin Exp Med, 5(1): 14-9. [Abstract] [Full-text]
2. Use of rhBMP-2 in combination with structural cortical allografts: clinical and radiographic outcomes in anterior lumbar spinal surgery.
   J Bone Joint Surg Am, 87(6): 1205-12. [Abstract] [Full-text]
3. Traumatic stress symptoms in adolescent organ transplant recipients.
   Pediatrics, 115(6): 1640-4. [Abstract] [Full-text]
4. Outcome of heart-lung and bilateral sequential lung transplantation for cystic fibrosis: a UK national study.
   Eur Respir J, 25(6): 964-9. [Abstract] [Full-text]
5. Diastolic coronary artery compression in a cardiac transplant recipient: treatment with a stent.
   Catheter Cardiovasc Interv, 65(2): 271-5. [Abstract] [Full-text]
6. High prevalence of gastroesophageal reflux in children after lung transplantation.
   Pediatr Pulmonol, 40(1): 68-71. [Abstract] [Full-text]
7. Impact of prior portosystemic shunt procedures on outcome of liver transplantation.
   Surgery, 137(6): 620-5. [Abstract] [Full-text]
8. Contrast-enhanced three-dimensional fast-spoiled gradient magnetic resonance angiography of the renal arteries for potential living renal transplant donors: a comparative study with digital subtraction angiography.
   Australas Radiol, 49(3): 214-7. [Abstract] [Full-text]
9. Memokath metallic stent in the treatment of transplant kidney ureter stenosis or occlusion.
   Cardiovasc Intervent Radiol, 28(3): 326-30. [Abstract] [Full-text]
10. Interventional radiology in liver transplantation.
    Cardiovasc Intervent Radiol, 28(3): 271-83. [Abstract] [Full-text]
11. CD25+CD4+ regulatory T cells generated by exposure to a model protein antigen prevent allograft rejection: antigen-specific reactivation in vivo is critical for bystander regulation.
    Blood, 105(12): 4871-7. [Abstract] [Full-text]
12. Organ transplantation--how much of the promise has been realized?
    Nat Med, 11(6): 605-13. [Abstract] [Full-text]
13. Coronary stenosis detection by 16-slice computed tomography in heart transplant patients: comparison with conventional angiography and impact on clinical management.
    J Am Coll Cardiol, 45(11): 1826-31. [Abstract] [Full-text]
14. Assessing glomerular filtration rate in renal transplant recipients by estimates derived from serum measurements of creatinine and cystatin C.
    Clin Chim Acta, 356(1): 204-11. [Abstract] [Full-text]
15. Impact of ELISA-detected anti-HLA antibodies on pediatric cardiac allograft outcome.
    Hum Immunol, 66(5): 513-8. [Abstract] [Full-text]
16. Acute and hyperacute humoral rejection in kidney allograft recipients treated with anti-human thymocyte antibodies.
    Hum Immunol, 66(5): 501-12. [Abstract] [Full-text]
17. Soluble CD30 and HLA antibodies as potential risk factors for kidney transplant rejection.
    Transpl Immunol, 14(2): 117-21. [Abstract] [Full-text]
18. EBV-specific memory CD8+ T cell phenotype and function in stable solid organ transplant patients.
    Transpl Immunol, 14(2): 109-16. [Abstract] [Full-text]
19. Quantitative detection of changes in cytokine gene expression in peripheral blood mononuclear cells correlates with and precedes acute rejection in renal transplant recipients.
    Transpl Immunol, 14(2): 99-108. [Abstract] [Full-text]
20. Liver recipients harbouring anti-donor preformed lymphocytotoxic antibodies exhibit a poor allograft survival at the first year after transplantation: experience of one centre.
    Transpl Immunol, 14(2): 91-7. [Abstract] [Full-text]
21. No association between tumor necrosis factor-alpha production and gene polymorphisms among inbred rat strains.
    Transpl Immunol, 14(2): 77-82. [Abstract] [Full-text]
22. Intraoperative blood loss during living donor liver transplantation: an analysis of 635 recipients at a single center.
    Transfusion, 45(6): 879-84. [Abstract] [Full-text]
23. The failed renal transplant: in or out?
    Semin Dial, 18(3): 188-9. [Abstract] [Full-text]
24. The management of the failed renal allograft: an enigma with potential consequences.
    Semin Dial, 18(3): 185-7. [Abstract] [Full-text]
25. At the peril of dialysis patients: ignoring the failed transplant.
    Semin Dial, 18(3): 180-4. [Abstract] [Full-text]
26. Primary graft dysfunction and other selected complications of lung transplantation: A single-center experience of 983 patients.
    J Thorac Cardiovasc Surg, 129(6): 1421-9. [Abstract] [Full-text]
27. Quality of life of patients having renal replacement therapy.
    J Adv Nurs, 51(1): 15-21. [Abstract] [Full-text]
28. Clinical effectiveness of processed and unprocessed bone.
    Transfus Med, 15(3): 165-74. [Abstract] [Full-text]
29. Concurrent verrucous and varicelliform rashes following renal transplantation.
    Am J Transplant, 5(7): 1777-80. [Abstract] [Full-text]
30. Transplantation and 6-month follow-up of renal transplantation from a donor with systemic lupus erythematosus and lupus nephritis.
    Am J Transplant, 5(7): 1772-6. [Abstract] [Full-text]
31. CD31+ naïve Th cells are stable during six months following kidney transplantation: implications for post-transplant thymic function.
    Am J Transplant, 5(7): 1764-71. [Abstract] [Full-text]
32. Reversibility of 'secondary hypercalcitoninemia' after kidney transplantation.
    Am J Transplant, 5(7): 1757-63. [Abstract] [Full-text]
33. Calcineurin inhibitor withdrawal from sirolimus-based therapy in kidney transplantation: a systematic review of randomized trials.
    Am J Transplant, 5(7): 1748-56. [Abstract] [Full-text]
34. Progressive chronic kidney disease after pediatric lung transplantation.
    Am J Transplant, 5(7): 1739-47. [Abstract] [Full-text]
35. Management of arterial stenosis affecting kidney graft perfusion: a single-centre study in 53 patients.
    Am J Transplant, 5(7): 1731-8. [Abstract] [Full-text]
36. Kidneys from deceased donors: maximizing the value of a scarce resource.
    Am J Transplant, 5(7): 1725-30. [Abstract] [Full-text]
37. Patient survival following renal transplant failure in Canada.
    Am J Transplant, 5(7): 1719-24. [Abstract] [Full-text]
38. Increasing incidence of post-kidney transplant anemia in children.
    Am J Transplant, 5(7): 1713-8. [Abstract] [Full-text]
39. Natural history of hepatitis C virus-related liver fibrosis after renal transplantation.
    Am J Transplant, 5(7): 1704-12. [Abstract] [Full-text]
40. Tailoring the type of donor hepatectomy for adult living donor liver transplantation.
    Am J Transplant, 5(7): 1694-703. [Abstract] [Full-text]
41. Early subclinical coronary artery calcification in young adults who were pediatric kidney transplant recipients.
    Am J Transplant, 5(7): 1689-93. [Abstract] [Full-text]
42. Are we frozen in time? Analysis of the utilization and efficacy of pulsatile perfusion in renal transplantation.
    Am J Transplant, 5(7): 1681-8. [Abstract] [Full-text]
43. Living donor kidney and autologous stem cell transplantation for primary systemic amyloidosis (AL) with predominant renal involvement.
    Am J Transplant, 5(7): 1660-70. [Abstract] [Full-text]
44. Split-liver transplantation: results of statewide usage of the right trisegmental graft.
    Am J Transplant, 5(7): 1652-9. [Abstract] [Full-text]
45. Split-liver transplantation using the left lateral segment: a collaborative sharing experience between two distant centers.
    Am J Transplant, 5(7): 1646-51. [Abstract] [Full-text]
46. A novel method for the assessment of cellular composition and beta-cell viability in human islet preparations.
    Am J Transplant, 5(7): 1635-45. [Abstract] [Full-text]
47. Indirect recognition of MHC class I allopeptides accelerates lung allograft rejection in miniature swine.
    Am J Transplant, 5(7): 1626-34. [Abstract] [Full-text]
48. Workshop on late renal allograft dysfunction.
    Am J Transplant, 5(7): 1600-5. [Abstract] [Full-text]
49. Reproduction and transplantation: report on the AST Consensus Conference on Reproductive Issues and Transplantation.
    Am J Transplant, 5(7): 1592-9. [Abstract] [Full-text]
50. Is it right to promote living donor liver transplantation for fulminant hepatic failure in pediatric recipients?
    Am J Transplant, 5(7): 1587-91. [Abstract] [Full-text]
51. Use of a mechanical thrombectomy device to recanalize a subacutely occluded aortohepatic bypass after orthotopic liver transplantation.
    J Endovasc Ther, 12(3): 401-4. [Abstract] [Full-text]
52. Structural allograft and primary press-fit cup for severe acetabular deficiency. A minimum 6-year follow-up study.
    Int Orthop, 29(3): 135-9. [Abstract] [Full-text]
53. Transjugular intrahepatic portosystemic shunt in a living donor left lateral segment liver transplant recipient: technical considerations.
    J Vasc Interv Radiol, 16(6): 873-7. [Abstract] [Full-text]
54. Hepatic artery stenosis in liver transplant recipients: primary treatment with percutaneous transluminal angioplasty.
    J Vasc Interv Radiol, 16(6): 795-805. [Abstract] [Full-text]
55. Identification of expandable human hepatic progenitors which differentiate into mature hepatic cells in vivo.
    Gut, 54(7): 972-9. [Abstract] [Full-text]
56. Influence of everolimus on steady-state pharmacokinetics of cyclosporine in maintenance renal transplant patients.
    J Clin Pharmacol, 45(7): 781-91. [Abstract] [Full-text]
57. Usefulness of relative lymphocyte count as an independent predictor of death/urgent transplant in heart failure.
    Am J Cardiol, 95(12): 1492-5. [Abstract] [Full-text]
58. Desperately seeking "normal": the promise and perils of living with kidney transplantation.
    Soc Sci Med, 61(4): 821-31. [Abstract] [Full-text]
59. Severe left ventricular dysfunction secondary to primary pulmonary hypertension: bridging therapy with bosentan before lung transplantation.
    J Heart Lung Transplant, 24(6): 777-80. [Abstract] [Full-text]
60. West Nile virus infection after cardiac transplantation.
    J Heart Lung Transplant, 24(6): 774-6. [Abstract] [Full-text]
61. Experience of percutaneous coronary intervention in the management of pediatric cardiac allograft vasculopathy.
    J Heart Lung Transplant, 24(6): 769-73. [Abstract] [Full-text]
62. Does lung transplantation improve health-related quality of life? The University of Florida experience.
    J Heart Lung Transplant, 24(6): 755-63. [Abstract] [Full-text]
63. Myocardial restoration with embryonic stem cell bioartificial tissue transplantation.
    J Heart Lung Transplant, 24(6): 737-44. [Abstract] [Full-text]
64. Formation of 4-hydroxy-2-nonenal protein adducts in the ischemic rat heart after transplantation.
    J Heart Lung Transplant, 24(6): 730-6. [Abstract] [Full-text]
65. Effects of short-term inhaled nitric oxide on interleukin-8 release after single-lung transplantation in pigs.
    J Heart Lung Transplant, 24(6): 714-22. [Abstract] [Full-text]
66. Effectivity of a T-cell-adapted induction therapy with anti-thymocyte globulin (Sangstat).
    J Heart Lung Transplant, 24(6): 708-13. [Abstract] [Full-text]
67. Is bridging to transplantation with a left ventricular assist device a risk factor for transplant coronary artery disease?
    J Heart Lung Transplant, 24(6): 703-7. [Abstract] [Full-text]
68. Osteoporosis in adult survivors of adolescent cardiac transplantation may be related to hyperparathyroidism, mild renal insufficiency, and increased bone turnover.
    J Heart Lung Transplant, 24(6): 696-702. [Abstract] [Full-text]
69. Projected survival benefit as criterion for listing and organ allocation in heart transplantation.
    J Heart Lung Transplant, 24(6): 680-9. [Abstract] [Full-text]
70. Lung retransplantation after posttransplantation lymphoproliferative disorder (PTLD): a single-center experience and review of literature of PTLD in lung transplant recipients.
    J Heart Lung Transplant, 24(6): 671-9. [Abstract] [Full-text]
71. Blunted vascular response to endothelin-a receptor blockade in cyclosporine-treated lung transplant recipients.
    J Heart Lung Transplant, 24(6): 665-70. [Abstract] [Full-text]
72. Reliability for grading acute rejection and airway inflammation after lung transplantation.
    J Heart Lung Transplant, 24(6): 652-7. [Abstract] [Full-text]
73. The impact and outcome of transplant coronary artery disease in a pediatric population: a 9-year multi-institutional study.
    J Heart Lung Transplant, 24(6): 645-51. [Abstract] [Full-text]
74. A history of orthotopic heart transplantation.
    Cardiol Rev, 13(4): 190-6. [Abstract] [Full-text]
75. Kidney transplantation with two donor ureters in patient with previous ileogastric conduit.
    Transpl Int, 18(7): 884-6. [Abstract] [Full-text]
76. Successful treatment with tenofovir in a child C cirrhotic patient with lamivudine-resistant hepatitis B virus awaiting liver transplantation. Post-transplant results.
    Transpl Int, 18(7): 879-83. [Abstract] [Full-text]
77. Ultrastructural analysis of the Fisher to Lewis rat model of chronic allograft nephropathy.
    Transpl Int, 18(7): 863-70. [Abstract] [Full-text]
78. OKT3 and ganciclovir treatments are possibly related to the presence of Epstein-Barr virus in serum after liver transplantation.
    Transpl Int, 18(7): 835-43. [Abstract] [Full-text]
79. Current practices of donor pancreas allocation in the UK: future implications for pancreas and islet transplantation.
    Transpl Int, 18(7): 828-34. [Abstract] [Full-text]
80. Clinical outcome of cadaveric renal allografts contaminated before transplantation.
    Transpl Int, 18(7): 824-7. [Abstract] [Full-text]
81. Open prospective multicenter study of conversion to tacrolimus therapy in renal transplant patients experiencing ciclosporin-related side-effects.
    Transpl Int, 18(7): 816-23. [Abstract] [Full-text]
82. Left and right lobe split-liver transplantation for two paediatric recipients from a 9-year-old donor.
    Transpl Int, 18(7): 811-5. [Abstract] [Full-text]
83. Cyclosporine dose reduction in stable renal transplant patients with high C2 level: simplified method of single C2 measurement and individualization of C0 target.
    Transpl Int, 18(7): 806-10. [Abstract] [Full-text]
84. C4d peritubular capillary staining in chronic allograft nephropathy and transplant glomerulopathy: an uncommon finding.
    Transpl Int, 18(7): 800-5. [Abstract] [Full-text]
85. Living donor liver transplantation for primary biliary cirrhosis: retrospective analysis of 50 patients in a single center.
    Transpl Int, 18(7): 794-9. [Abstract] [Full-text]
86. Impact of pretransplant dialysis on early graft function in pediatric kidney recipients.
    Transpl Int, 18(7): 785-93. [Abstract] [Full-text]
87. Prevalence of cancer history prior to renal transplantation.
    Transpl Int, 18(7): 779-84. [Abstract] [Full-text]
88. Use of Neoral C monitoring: a European consensus.
    Transpl Int, 18(7): 768-78. [Abstract] [Full-text]
89. A simple new technique to prevent bleeding in transplant nephrectomy.
    Int J Urol, 12(5): 522-4. [Abstract] [Full-text]
90. Basal cell carcinoma with matrical differentiation in a transplant patient: a case report and review of the literature.
    J Cutan Pathol, 32(6): 445-8. [Abstract] [Full-text]
91. Applicability of adult-to-adult living donor liver transplantation.
    J Hepatol, 43(1): 104-9. [Abstract] [Full-text]
92. Combined treatment with pegylated interferon (alpha-2b) and ribavirin in the acute phase of hepatitis C virus recurrence after liver transplantation.
    J Hepatol, 43(1): 53-9. [Abstract] [Full-text]
93. Percutaneous transluminal angioplasty of an occluded surgical splenorenal shunt in a 4-year-old child after liver transplantation.
    Pediatr Radiol, 35(7): 688-90. [Abstract] [Full-text]
94. Relaxin as an additional protective substance in preserving and reperfusion solution for liver transplantation, shown in a model of isolated perfused rat liver.
    Ann N Y Acad Sci, 1041: 434-40. [Abstract] [Full-text]
95. Rabies encephalomyelitis: clinical, neuroradiological, and pathological findings in 4 transplant recipients.
    Arch Neurol, 62(6): 873-82. [Abstract] [Full-text]
96. The first organ transplant from a brain-dead donor.
    Neurology, 64(11): 1938-42. [Abstract] [Full-text]
97. Hepatic natural killer and natural killer T cells markedly decreased in two cases of drug-induced fulminant hepatic failure rescued by living donor liver transplantation.
    J Gastroenterol Hepatol, 20(7): 1126-30. [Abstract] [Full-text]
98. Plasma propofol concentrations during orthotopic liver transplantation.
    Acta Anaesthesiol Scand, 49(6): 804-10. [Abstract] [Full-text]
99. Survival of liver transplant candidates with acute renal failure receiving renal replacement therapy.
    Kidney Int, 68(1): 362-70. [Abstract] [Full-text]
100. Modifiable factors predicting patient survival in elderly kidney transplant recipients.
     Kidney Int, 68(1): 345-51. [Abstract] [Full-text]
101. Kidney transplantation and wait-listing rates from the international Dialysis Outcomes and Practice Patterns Study (DOPPS).
     Kidney Int, 68(1): 330-7. [Abstract] [Full-text]
102. Chronic renal allograft rejection: pathophysiologic considerations.
     Kidney Int, 68(1): 1-13. [Abstract] [Full-text]
103. Glutamatergic reinnervation through peripheral nerve graft dictates assembly of glutamatergic synapses at rat skeletal muscle.
     Proc Natl Acad Sci U S A, 102(24): 8752-7. [Abstract] [Full-text]
104. Epstein-Barr virus-related primary central nervous system lymphoma after cadaveric renal transplantation improved by treatment with high-dose methotrexate followed by irradiation.
     Nephrology (Carlton), 10(3): 321-4. [Abstract] [Full-text]
105. Pregnancy outcome after maternal organ transplantation in Sweden.
     BJOG, 112(7): 904-9. [Abstract] [Full-text]
106. Complete remission of post-transplant FSGS recurrence by long-term plasmapheresis.
     Pediatr Nephrol, 20(7): 994-7. [Abstract] [Full-text]
107. Antiviral medications to prevent cytomegalovirus disease and early death in recipients of solid-organ transplants: a systematic review of randomised controlled trials.
     Lancet, 365(9477): 2105-15. [Abstract] [Full-text]
108. Circulating endothelial cells in renal transplant recipients.
     Transplant Proc, 37(5): 2387-90. [Abstract] [Full-text]
109. CTLA4-Fas ligand gene transfer mediated by adenovirus induce long-time survival of murine cardiac allografts.
     Transplant Proc, 37(5): 2379-81. [Abstract] [Full-text]
110. Transforming growth factor beta1-modified donor cell transfusion induced allo-heart tolerance.
     Transplant Proc, 37(5): 2360-4. [Abstract] [Full-text]
111. Immunosuppression by combined use of cyclosporine and resveratrol in a rat liver transplantation model.
     Transplant Proc, 37(5): 2354-9. [Abstract] [Full-text]
112. Evaluation of intraoperative infusion solution using a complete anhepatic model in baby pigs.
     Transplant Proc, 37(5): 2341-6. [Abstract] [Full-text]
113. Guidelines for prevention and management of complications following kidney transplantation in rats.
     Transplant Proc, 37(5): 2333-7. [Abstract] [Full-text]
114. A rat model of chronic allograft liver rejection.
     Transplant Proc, 37(5): 2327-32. [Abstract] [Full-text]
115. Impact of mycophenolate mofetil loading on drug exposure in the early posttransplant period.
     Transplant Proc, 37(5): 2320-3. [Abstract] [Full-text]
116. Cyclosporine and sirolimus interaction in a kidney transplant patient.
     Transplant Proc, 37(5): 2317-9. [Abstract] [Full-text]
117. Embolization of a ruptured pseudoaneurysm with massive hemorrhage following pancreas transplantation: a case report.
     Transplant Proc, 37(5): 2275-7. [Abstract] [Full-text]
118. CD4-veCD8-ve CD30+ve T cells are detectable in human lung transplant patients and their proportion of the lymphocyte population after in vitro stimulation with donor spleen cells correlates with preservation of lung physiology.
     Transplant Proc, 37(5): 2257-60. [Abstract] [Full-text]
119. The frequency of interleukin-10- and interleukin-5-secreting CD4+ T cells correlates to tolerance of transplanted lung.
     Transplant Proc, 37(5): 2255-6. [Abstract] [Full-text]
120. Successful heart transplantation after 13 hours of donor heart ischemia with the use of HTK solution: a case report.
     Transplant Proc, 37(5): 2253-4. [Abstract] [Full-text]
121. Liver transplant combined with heart transplant in severe heterozygous hypercholesterolemia: report of the first case and review of the literature.
     Transplant Proc, 37(5): 2250-2. [Abstract] [Full-text]
122. Donor CCR5 Delta32 polymorphism and outcome following cardiac transplantation.
     Transplant Proc, 37(5): 2247-9. [Abstract] [Full-text]
123. Impact of cardiac transplantation in 24 hours circadian blood pressure and heart rate profile.
     Transplant Proc, 37(5): 2244-6. [Abstract] [Full-text]
124. Therapeutic mycophenolic acid monitoring by means of limited sampling strategy in orthotopic heart transplant patients.
     Transplant Proc, 37(5): 2240-3. [Abstract] [Full-text]
125. De novo immunosuppression with sirolimus and tacrolimus in heart transplant recipients compared with cyclosporine and mycophenolate mofetil: a one-year follow-up analysis.
     Transplant Proc, 37(5): 2231-9. [Abstract] [Full-text]
126. Factors in association with sepsis after liver transplantation: the Hungarian experience.
     Transplant Proc, 37(5): 2227-8. [Abstract] [Full-text]
127. Liver failure in transplanted liver due to Amanita falloides.
     Transplant Proc, 37(5): 2224-6. [Abstract] [Full-text]
128. Clinicopathological review of 18 cases of liver allografts lost due to bile duct necrosis.
     Transplant Proc, 37(5): 2221-3. [Abstract] [Full-text]
129. Liver transplantation for familial amyloid polyneuropathy non-VAL30MET variants: are cardiac complications influenced by prophylactic pacing and immunosuppressive weaning?
     Transplant Proc, 37(5): 2214-20. [Abstract] [Full-text]
130. Preoperative dobutamine stress echocardiography, intraoperative events, and intraoperative myocardial injury in liver transplantation.
     Transplant Proc, 37(5): 2209-13. [Abstract] [Full-text]
131. Peginterferon and ribavirin in patients with HCV cirrhosis after liver transplantation.
     Transplant Proc, 37(5): 2207-8. [Abstract] [Full-text]
132. De novo hepatocellular carcinoma in a liver allograft associated with recurrent hepatitis B.
     Transplant Proc, 37(5): 2205-6. [Abstract] [Full-text]
133. Is hepatitis B immunoglobulin prophylaxis needed for liver transplantation in the era of new antivirals?
     Transplant Proc, 37(5): 2200-4. [Abstract] [Full-text]
134. Hepatic angiosarcoma and liver transplantation: case report and literature review.
     Transplant Proc, 37(5): 2195-9. [Abstract] [Full-text]
135. Ki-67 proliferation index in Kaposi's sarcoma after renal transplantation: findings in skin-only cases versus cases with internal-organ involvement.
     Transplant Proc, 37(5): 2190-4. [Abstract] [Full-text]
136. Successful treatment of liver transplant-associated Kaposi's sarcoma with long-term vincristine.
     Transplant Proc, 37(5): 2188-9. [Abstract] [Full-text]
137. Successful use of sirolimus in a patient with bulky ovarian metastasis of hepatocellular carcinoma after liver transplantation.
     Transplant Proc, 37(5): 2185-7. [Abstract] [Full-text]
138. Orthotopic liver transplantation for incurable alveolar echinococcosis: report of five cases from west China.
     Transplant Proc, 37(5): 2181-4. [Abstract] [Full-text]
139. Treatment of steroid-resistant acute liver transplant rejection with basiliximab.
     Transplant Proc, 37(5): 2179-80. [Abstract] [Full-text]
140. MELD scores do not predict patient morbidity while on the liver transplant waiting list.
     Transplant Proc, 37(5): 2174-8. [Abstract] [Full-text]
141. Mortality while awaiting liver retransplantation: predictability of MELD scores.
     Transplant Proc, 37(5): 2172-3. [Abstract] [Full-text]
142. What is the best immunosuppression in living donor liver transplantation?
     Transplant Proc, 37(5): 2169-71. [Abstract] [Full-text]
143. Liver transplant with portocaval hemitransposition: blood supply with only hepatic artery is possible?
     Transplant Proc, 37(5): 2163-5. [Abstract] [Full-text]
144. Orthotopic liver transplantation with vena cava preservation in cirrhotic patients: is systematic temporary portacaval anastomosis a justified procedure?
     Transplant Proc, 37(5): 2159-62. [Abstract] [Full-text]
145. Study of surgical complications between primary and secondary renal transplants.
     Transplant Proc, 37(5): 2154-6. [Abstract] [Full-text]
146. Correlations between leptin, body composition, bone mineral density, and bone metabolism in kidney transplant recipients.
     Transplant Proc, 37(5): 2151-3. [Abstract] [Full-text]
147. Anemia due to losartan in hypertensive renal transplant recipients without posttransplant erythrocytosis.
     Transplant Proc, 37(5): 2148-50. [Abstract] [Full-text]
148. A simulation model to investigate the impact of cardiovascular risk in renal transplantation.
     Transplant Proc, 37(5): 2135-43. [Abstract] [Full-text]
149. Increased expression of renin in chronic allograft nephropathy.
     Transplant Proc, 37(5): 2131-4. [Abstract] [Full-text]
150. The role of cholecystectomy in renal transplantation.
     Transplant Proc, 37(5): 2129-30. [Abstract] [Full-text]
151. Laparoscopic cholecystectomy for renal transplants.
     Transplant Proc, 37(5): 2127-8. [Abstract] [Full-text]
152. Influence of ganciclovir prophylaxis on citomegalovirus, human herpesvirus 6, and human herpesvirus 7 viremia in renal transplant recipients.
     Transplant Proc, 37(5): 2124-6. [Abstract] [Full-text]
153. Klebsiella pneumoniae peritonitis shortly after kidney transplantation.
     Transplant Proc, 37(5): 2122-3. [Abstract] [Full-text]
154. Variation of CD4+ and CD8+ T lymphocytes as predictor of outcome in renal allograft recipients who developed acute respiratory distress syndrome caused by cytomegalovirus pneumonia.
     Transplant Proc, 37(5): 2118-21. [Abstract] [Full-text]
155. An unusual cause of ureteral obstruction in a renal transplant recipient: ureteric aspergilloma.
     Transplant Proc, 37(5): 2115-7. [Abstract] [Full-text]
156. Percutaneous management of transplant ureteral fistulae is feasible in selected cases.
     Transplant Proc, 37(5): 2111-4. [Abstract] [Full-text]
157. Kidney preserving solutions containing lidocaine may increase urological complication rate after renal transplantation: an in vitro study.
     Transplant Proc, 37(5): 2107-10. [Abstract] [Full-text]
158. Management of coralliform lithiasis on renal allograft with bricker-type ureterointestinal anastomosis.
     Transplant Proc, 37(5): 2104-6. [Abstract] [Full-text]
159. Sildenafil citrate treatment for erectile dysfunction after kidney transplantation.
     Transplant Proc, 37(5): 2100-3. [Abstract] [Full-text]
160. Experiences in kidney transplantation with duplicated ureters.
     Transplant Proc, 37(5): 2096-9. [Abstract] [Full-text]
161. Multiple neoplastic lesions of the lower genital tract in a human papilloma virus-infected kidney-pancreas allograft recipient: a case report.
     Transplant Proc, 37(5): 2093-5. [Abstract] [Full-text]
162. Therapy and prognosis of tumors of the genitourinary tract after kidney transplantation.
     Transplant Proc, 37(5): 2089-92. [Abstract] [Full-text]
163. Hepatocellular carcinoma in renal transplant patients.
     Transplant Proc, 37(5): 2086-8. [Abstract] [Full-text]
164. Hepatitis C virus reactivation in anti-hepatitic C virus-positive renal transplant recipients.
     Transplant Proc, 37(5): 2083-5. [Abstract] [Full-text]
165. Lack of impact of hepatitis C virus coinfection in end-stage renal disease patients with hepatitis B virus infection.
     Transplant Proc, 37(5): 2080-2. [Abstract] [Full-text]
166. Diabetic retinopathy before and after renal transplantation: a longitudinal study.
     Transplant Proc, 37(5): 2077-9. [Abstract] [Full-text]
167. Quality of sleep and quality of life in renal transplantation patients.
     Transplant Proc, 37(5): 2072-6. [Abstract] [Full-text]
168. The cost-effectiveness of basiliximab induction in "old-to-old" kidney transplant programs: Bayesian estimation, simulation, and uncertainty analysis.
     Transplant Proc, 37(5): 2069-71. [Abstract] [Full-text]
169. Early experience with enteric-coated mycophenolate sodium in de novo kidney transplant recipients.
     Transplant Proc, 37(5): 2066-8. [Abstract] [Full-text]
170. Diffuse vascular damage in a transplanted kidney: an indication for nuclear magnetic resonance?
     Transplant Proc, 37(5): 2063-5. [Abstract] [Full-text]
171. Comparison of long-term actual renal allograft survival in mycophenolate mofetil and azathioprine-based triple drug immunosuppression protocols.
     Transplant Proc, 37(5): 2060-2. [Abstract] [Full-text]
172. Delayed renal graft function: the influence of immunosuppression.
     Transplant Proc, 37(5): 2054-9. [Abstract] [Full-text]
173. Different evolution of trough and dose levels during the first year after transplantation for tacrolimus versus cyclosporine.
     Transplant Proc, 37(5): 2051-3. [Abstract] [Full-text]
174. Factors contributing to acute rejection in renal transplantation: the role of noncompliance.
     Transplant Proc, 37(5): 2044-7. [Abstract] [Full-text]
175. Blood cyclosporine level soon after kidney transplantation is a major determinant of rejection: insights from the Mycophenolate Steroid-Sparing Trial.
     Transplant Proc, 37(5): 2037-40. [Abstract] [Full-text]
176. Campath-1H as rescue therapy for the treatment of acute rejection in kidney transplant patients.
     Transplant Proc, 37(5): 2032-6. [Abstract] [Full-text]
177. A randomized study comparing combined spinal epidural or general anesthesia for renal transplant surgery.
     Transplant Proc, 37(5): 2020-2. [Abstract] [Full-text]
178. Comparison of histidine-tryptophan ketoglutarate and University of Wisconsin solutions as primary preservation in renal allografts undergoing pulsatile perfusion.
     Transplant Proc, 37(5): 2016-9. [Abstract] [Full-text]
179. A proposed Saudi approach to the ethical utilization of living unrelated kidney donation.
     Transplant Proc, 37(5): 2004-6. [Abstract] [Full-text]
180. Public knowledge and attitudes toward organ donation and transplantation: a cross-cultural study.
     Transplant Proc, 37(5): 1993-7. [Abstract] [Full-text]
181. Challenges of organ transplantation.
     Transplant Proc, 37(5): 1979-83. [Abstract] [Full-text]
182. Magnetic resonance imaging as a sole method for the morphological and functional evaluation of live kidney donors.
     BJU Int, 96(1): 111-6. [Abstract] [Full-text]
183. Effect of hepatitis C infection on tacrolimus doses and blood levels in liver transplantation recipients.
     Aliment Pharmacol Ther, 22(1): 37-44. [Abstract] [Full-text]
184. The outcome of surgical resection versus assignment to the liver transplant waiting list for hepatocellular carcinoma.
     Ann Surg Oncol, 12(7): 552-60. [Abstract] [Full-text]
185. Monitoring for human cytomegalovirus infection in solid organ transplant recipients through antigenemia and glycoprotein N (gN) variants: evidence of correlation and potential prognostic value of gN genotypes.
     Microbes Infect, 7(5): 890-6. [Abstract] [Full-text]
186. Protective mechanisms of a metalloporphyrinic peroxynitrite decomposition catalyst, WW85, in rat cardiac transplants.
     J Pharmacol Exp Ther, 314(1): 53-60. [Abstract] [Full-text]
187. Hepatofugal portal flow due to acute cellular rejection.
     Abdom Imaging, 30(3): 303-5. [Abstract] [Full-text]
188. Retroperitoneoscopic donor nephrectomy: a retrospective, non-randomized comparison of early complications, donor and recipient outcome with the standard open approach.
     Eur Urol, 48(1): 90-6; discussion 96. [Abstract] [Full-text]
189. Duplex-Doppler long-term follow-up of renal transplant artery stenosis: case controlled study.
     Ther Apher Dial, 9(3): 265-9. [Abstract] [Full-text]
190. Prevention of early acute rejection with daclizumab and triple immunosuppression in cadaveric renal allograft recipients.
     Ther Apher Dial, 9(3): 262-4. [Abstract] [Full-text]
191. The impact of early cytomegalovirus infection and disease in renal transplant recipients.
     Clin Microbiol Infect, 11(7): 518-30. [Abstract] [Full-text]
192. The calcimimetic cinacalcet normalizes serum calcium in renal transplant patients with persistent hyperparathyroidism.
     Nephrol Dial Transplant, 20(7): 1311-4. [Abstract] [Full-text]
193. Successful treatment of hypercalcemia with cinacalcet in renal transplant recipients with persistent hyperparathyroidism.
     Nephrol Dial Transplant, 20(7): 1315-9. [Abstract] [Full-text]
194. Limitations of C2 monitoring in renal transplant recipients.
     Nephrol Dial Transplant, 20(7): 1463-70. [Abstract] [Full-text]
195. Arthroplasty of the elbow joint using vascularized iliac bone graft for reconstruction of massive bone defect of the distal humerus.
     J Reconstr Microsurg, 21(5): 287-91. [Abstract] [Full-text]
196. A novel approach to managing variation: outpatient therapeutic monitoring of calcineurin inhibitor blood levels in liver transplant recipients.
     J Pediatr, 146(6): 744-50. [Abstract] [Full-text]
197. Extracorporeal irradiated autogenous osteochondral graft: a histological study.
     J Bone Joint Surg Br, 87(7): 1006-11. [Abstract] [Full-text]
198. Vascular closure staples for portal vein reconstruction in living-donor liver transplantation.
     Am J Surg, 190(1): 65-8. [Abstract] [Full-text]
199. Oxidative mitochondrial DNA damage and deletion in hepatocytes of rejecting liver allografts in rats: role of TNF-alpha.
     Hepatology, 42(1): 208-15. [Abstract] [Full-text]
200. Hepatic targeting of transplanted liver sinusoidal endothelial cells in intact mice.
     Hepatology, 42(1): 140-8. [Abstract] [Full-text]
201. Chest tube suction-associated unilateral negative pressure pulmonary edema in a lung transplant patient.
     Anesth Analg, 101(1): 38-40, table of contents. [Abstract] [Full-text]
202. A comparison of transfusion requirements between living donation and cadaveric donation liver transplantation: relationship to model of end-stage liver disease score and baseline coagulation status.
     Anesth Analg, 101(1): 30-7, table of contents. [Abstract] [Full-text]
203. Practice of adult liver transplantation in Italy. Recommendations of the Italian Association for the Study of the Liver (A.I.S.F.).
     Dig Liver Dis, 37(7): 461-7. [Abstract] [Full-text]
204. Post-transplant diabetes mellitus: risk factors, frequency of transplant rejections, and long-term prognosis.
     Clin Exp Nephrol, 9(2): 164-9. [Abstract] [Full-text]
205. Oromandibular reconstruction after cancer resection.
     Clin Plast Surg, 32(3): 361-75, vi. [Abstract] [Full-text]
206. Treatment of scaphoid non-union with a percutaneous corticocancellous bone graft.
     J Hand Surg [Br], 30(4): 365-8. [Abstract] [Full-text]
207. Lung transplantation for cystic fibrosis: 6-year follow-up.
     J Cyst Fibros, 4(2): 107-14. [Abstract] [Full-text]
208. Pre-treatment of donor with 1-deamino-8-d-arginine vasopressin could alleviate early failure of porcine xenograft in a cobra venom factor treated canine recipient.
     Eur J Cardiothorac Surg, 28(1): 149-56. [Abstract] [Full-text]
209. Outcome of hearts with cold ischemic time greater than 300 minutes. A case-matched study.
     Eur J Cardiothorac Surg, 28(1): 143-8. [Abstract] [Full-text]
210. Prognostic assays for rejection and tolerance in organ transplantation.
     Transpl Immunol, 14(3): 193-201. [Abstract] [Full-text]
211. Systematic review and validation of prognostic models in liver transplantation.
     Liver Transpl, 11(7): 814-25. [Abstract] [Full-text]
212. Liver transplantation for cardiac failure in patients with hereditary hemorrhagic telangiectasia.
     Liver Transpl, 11(7): 834-8. [Abstract] [Full-text]
213. Pharmacogenetic association with adverse drug reactions to azathioprine immunosuppressive therapy following liver transplantation.
     Liver Transpl, 11(7): 826-33. [Abstract] [Full-text]
214. Liver transplantation for chronic hepatitis B with lamivudine-resistant YMDD mutant using add-on adefovir dipivoxil plus lamivudine.
     Liver Transpl, 11(7): 807-13. [Abstract] [Full-text]
215. Critical analysis of the pediatric end-stage liver disease scoring system: a single center experience.
     Liver Transpl, 11(7): 788-95. [Abstract] [Full-text]
216. Changes in oxyhemoglobin dissociation curve in intrabdominal organs during pig experimental orthotopic liver transplantation.
     Liver Transpl, 11(7): 760-6. [Abstract] [Full-text]
217. Mycophenolate mofetil combination therapy improves long-term outcomes after liver transplantation in patients with and without hepatitis C.
     Liver Transpl, 11(7): 750-9. [Abstract] [Full-text]
218. Liver transplantation for HCV-related cirrhosis in a patient with gastric mucosa-associated lymphoma (MALToma) pretreated with rituximab.
     Liver Transpl, 11(7): 839-42. [Abstract] [Full-text]
219. "All-in-one" imaging protocols for the evaluation of potential living liver donors: comparison of magnetic resonance imaging and multidetector computed tomography.
     Liver Transpl, 11(7): 776-87. [Abstract] [Full-text]
220. Impact of pretransplantation transarterial chemoembolization on survival and recurrence after liver transplantation for hepatocellular carcinoma.
     Liver Transpl, 11(7): 767-75. [Abstract] [Full-text]
221. Right hepatic lobe donation adversely affects donor life insurability up to one year after donation.
     Liver Transpl, 11(7): 843-7. [Abstract] [Full-text]
222. Tissue-engineered patch for the reconstruction of inferior vena cava during living-donor liver transplantation.
     J Gastrointest Surg, 9(6): 789-93. [Abstract] [Full-text]
223. Modified endoscopic live donor nephrectomy: retroperitoneoscopy followed by hand-assistance.
     Int J Urol, 12(6): 603-6. [Abstract] [Full-text]
224. Severe hypogammaglobulinemia associated with hepatic vein stenosis causes cytomegalovirus infection after living-related liver transplantation.
     Transpl Infect Dis, 7(1): 41-4. [Abstract] [Full-text]
225. Disseminated toxoplasmosis with pulmonary involvement after heart transplantation.
     Transpl Infect Dis, 7(1): 38-40. [Abstract] [Full-text]
226. Human herpesvirus-8-related Kaposi's sarcoma after liver transplantation successfully treated with cidofovir and liposomal daunorubicin.
     Transpl Infect Dis, 7(1): 34-7. [Abstract] [Full-text]
227. Long-term remission of recurrent parvovirus-B associated anemia in a renal transplant recipient induced by treatment with immunoglobulin and positive seroconversion.
     Transpl Infect Dis, 7(1): 30-3. [Abstract] [Full-text]
228. Cryptococcosis after living donor liver transplantation: report of three cases.
     Transpl Infect Dis, 7(1): 26-9. [Abstract] [Full-text]
229. Living-donor kidney transplantation: a review of the current practices for the live donor.
     J Am Soc Nephrol, 16(7): 2098-110. [Abstract] [Full-text]
230. Recurrence of membranoproliferative glomerulonephritis type II in renal allografts: The North American Pediatric Renal Transplant Cooperative Study experience.
     J Am Soc Nephrol, 16(7): 2225-33. [Abstract] [Full-text]
231. Glucose and lipid metabolism after liver transplantation in inbred rats: consequences of hepatic denervation.
     Metabolism, 54(7): 881-90. [Abstract] [Full-text]
232. Daclizumab to prevent rejection after cardiac transplantation.
     N Engl J Med, 352(26): 2705-13. [Abstract] [Full-text]
233. Mini-BEAM and autologous hematopoietic stem-cell transplant for treatment of post-transplant lymphoproliferative disorders.
     Am J Hematol, 79(3): 211-5. [Abstract] [Full-text]
234. Intrahepatic cytokine profile in renal-transplant patients infected by hepatitis C virus.
     J Med Virol, 76(4): 482-8. [Abstract] [Full-text]
235. Treatment of hepatic venous outflow obstruction after piggyback liver transplantation.
     Radiology, 236(1): 352-9. [Abstract] [Full-text]

© 2004-2011 Organ Transplantation Research Today. All Rights Reserved.